Aardvark Therapeutics(Aard) Financials: Fixed Asset Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - fixed asset turnover
This chart shows the historical trend of fixed asset turnover for AARD compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Fixed Asset Turnover
Definition: Fixed asset turnover shows how well the company’s long-term physical assets — factories, equipment, property — are being used to generate sales. A high ratio means the company’s facilities are productive and efficient. A low ratio might signal underused assets or over-investment in equipment that isn’t driving enough sales.
Interpretation:
• In '2022', AARD's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 1.43.
• In '2023', AARD's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. The figure remained stable compared to '2022'. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.31. Industry average declined by 0.12 from previous year.
• In '2024', AARD's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. The figure remained stable compared to '2023'. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 1.42. Industry average increased by 0.11 compared to previous year.
Overall, AARD's fixed asset turnover has remained generally stable over the past 3 years.
Formula: Fixed Asset Turnover = Net Sales / Net Fixed Assets
Good Range: Ranges from 1 to 5 depending on asset intensity.